| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Epinephrine 10 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely bimatoprost 300 microgram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| sennosid B (som sennosid) 1,5 milligram/milliliter, oral lösning |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| Amisulpride 100 mg/mL oral solution |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Pilocarpine hydrochloride 5 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely simeticone 8.4 milligram/1 milliliter conventional release oral drops (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Selegiline hydrochloride 2 mg/mL oral solution |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely sirolimus 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Atropine sulfate 10 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Chloramphenicol 5 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely ranitidine (as ranitidine hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Paracetamol 100 mg/mL oral solution |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely glutaraldehyde 100 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely pseudoephedrine hydrochloride 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely sodium fluoride 20 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| fenylefrinhydroklorid 5 milligram/milliliter och lidokainhydroklorid 50 milligram/milliliter, kutan sprej, lösning |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fenylefrinhydroklorid 5 milligram/milliliter och lidokainhydroklorid 50 milligram/milliliter, kutan sprej, lösning |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
| Pilocarpine hydrochloride 30 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely chlorhexidine gluconate 2 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Clobetasone butyrate 1 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Cocaine hydrochloride 40 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Chlorhexidine gluconate 1 mg/mL and chlorobutanol 5 mg/mL oromucosal solution |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
2 |
| Chlorhexidine gluconate 1 mg/mL and chlorobutanol 5 mg/mL oromucosal solution |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely diazepam 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely framycetin sulfate 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Sodium chloride 50 mg/mL eye drops |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely hexetidine 1 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| betaxolol 0,25 %, ögondroppar |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| natriumkromoglikat 2 %, ögondroppar |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| atrakuriumbesylat 25 mg/2,5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| atrakuriumbesylat 25 mg/2,5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| Product containing precisely atovaquone 150 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength denominator unit |
True |
mL |
Inferred relationship |
Some |
1 |
| flukonazol 50 mg/25 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flukonazol 50 mg/25 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| atrakuriumbesylat 250 mg/25 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| atrakuriumbesylat 250 mg/25 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| dinoproston 5 mg/0,5 ml, infusionsväska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| dinoproston 5 mg/0,5 ml, infusionsväska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flucytosin 2,5 g/250 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flucytosin 2,5 g/250 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| atrakuriumbesylat 50 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| atrakuriumbesylat 50 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flumazenil 500 mikrogram/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flumazenil 500 mikrogram/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dipyridamol 10 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dipyridamol 10 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fluorouracil (som fluorouracilnatrium) 2,5 g/100 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fluorouracil (som fluorouracilnatrium) 2,5 g/100 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| atropinsulfat 1 mg/10 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| atropinsulfat 1 mg/10 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| pamidronatdinatrium 60 mg/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| pamidronatdinatrium 60 mg/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fluorouracil (som fluorouracilnatrium) 250 mg/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fluorouracil (som fluorouracilnatrium) 250 mg/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| baklofen 10 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| baklofen 10 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| bemiparinnatrium 2 500 enheter/0,2 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| bemiparinnatrium 2 500 enheter/0,2 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| pamidronatdinatrium 90 mg/30 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| pamidronatdinatrium 90 mg/30 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 100 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 100 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| disopyramid (som disopyramidfosfat) 50 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| disopyramid (som disopyramidfosfat) 50 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 50 mg/0,5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 50 mg/0,5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| dobutamin (som dobutaminhydroklorid) 250 mg/20 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| dobutamin (som dobutaminhydroklorid) 250 mg/20 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 200 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 200 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fosfolipid (som beraktant) 200 mg/8 ml, suspension för endotrakeopulmonell instillation, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fosfolipid (som beraktant) 200 mg/8 ml, suspension för endotrakeopulmonell instillation, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| enoxaparinnatrium 120 mg/0,8 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| enoxaparinnatrium 120 mg/0,8 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dobutamin (som dobutaminhydroklorid) 250 mg/5 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| dobutamin (som dobutaminhydroklorid) 250 mg/5 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 20 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 20 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| betametason (som betametasonnatriumfosfat) 4 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| betametason (som betametasonnatriumfosfat) 4 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 40 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flupentixoldekanoat 40 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| enoxaparinnatrium 150 mg/ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| enoxaparinnatrium 150 mg/ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| dopaminhydroklorid 800 mg/5 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| dopaminhydroklorid 800 mg/5 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| flufenazindekanoat 50 mg/0,5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flufenazindekanoat 50 mg/0,5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dopaminhydroklorid 200 mg/5 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dopaminhydroklorid 200 mg/5 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| diazepam 10 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| diazepam 10 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flufenazindekanoat 100 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| flufenazindekanoat 100 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| bretyliumtosylat 500 mg/10 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |